ELISA analysis of global methylation levels

Oliveira, Naila Francis Paulo de; Coêlho, Marina de Castro; Filho, José Maria Chagas Viana

doi:10.1016/b978-0-12-819414-0.00005-7

Cited by 3 publications

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, the global methylation level (5mC%) was measured to validate our in-silico results (De Oliveira et al, 2020). We tested the chicoric acid on the HCT116 cell line at 2.5, 5 and 7.5 µM doses.…”

Section: Discussionmentioning

confidence: 99%

Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity

et al. 2022

View full text Add to dashboard Cite

Ubiquitin-like containing plant homeodomain Ring Finger 1 (UHRF1) protein is recognized as a cell-cycle-regulated multidomain protein. UHRF1 importantly manifests the maintenance of DNA methylation mediated by the interaction between its SRA (SET and RING associated) domain and DNA methyltransferase-1 (DNMT1)-like epigenetic modulators. However, overexpression of UHRF1 epigenetically responds to the aberrant global methylation and promotes tumorigenesis. To date, no potential molecular inhibitor has been studied against the SRA domain. Therefore, this study focused on identifying the active natural drug-like candidates against the SRA domain. A comprehensive set of in silico approaches including molecular docking, molecular dynamics (MD) simulation, and toxicity analysis was performed to identify potential candidates. A dataset of 709 natural compounds was screened through molecular docking where chicoric acid and nystose have been found showing higher binding affinities to the SRA domain. The MD simulations also showed the protein ligand interaction stability of and in silico toxicity analysis has also showed chicoric acid as a safe and nontoxic drug. In addition, chicoric acid possessed a longer interaction time and higher LD50 of 5000 mg/kg. Moreover, the global methylation level (%5 mC) has been assessed after chicoric acid treatment was in the colorectal cancer cell line (HCT116) at different doses. The result showed that 7.5 µM chicoric acid treatment reduced methylation levels significantly. Thus, the study found chicoric acid can become a possible epidrug-like inhibitor against the SRA domain of UHRF1 protein.

show abstract

Section: Discussionmentioning

confidence: 99%